These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34100060)

  • 1. Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers.
    Eggers KM; Lindhagen L; Lindhagen L; Baron T; Erlinge D; Hjort M; Jernberg T; Marko-Varga G; Rezeli M; Spaak J; Lindahl B
    Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):806-812. PubMed ID: 34100060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction.
    Skau E; Henriksen E; Wagner P; Hedberg P; Siegbahn A; Leppert J
    Eur J Prev Cardiol; 2017 Oct; 24(15):1576-1583. PubMed ID: 28762762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry.
    Eggers KM; Lindhagen L; Baron T; Erlinge D; Hjort M; Jernberg T; Johnston N; Marko-Varga G; Rezeli M; Spaak J; Lindahl B
    PLoS One; 2021; 16(4):e0249830. PubMed ID: 33831096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide molecular forms for risk stratification and prediction of outcome after acute myocardial infarction.
    Israr MZ; Heaney LM; Ng LL; Suzuki T
    Am Heart J; 2018 Jun; 200():37-43. PubMed ID: 29898847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial.
    Ferreira JP; Sharma A; Mehta C; Bakris G; Rossignol P; White WB; Zannad F
    Clin Res Cardiol; 2021 Jul; 110(7):1006-1019. PubMed ID: 32789678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarction.
    Edfors R; Lindhagen L; Spaak J; Evans M; Andell P; Baron T; Mörtberg J; Rezeli M; Salzinger B; Lundman P; Szummer K; Tornvall P; Wallén HN; Jacobson SH; Kahan T; Marko-Varga G; Erlinge D; James S; Lindahl B; Jernberg T
    J Intern Med; 2020 Nov; 288(5):581-592. PubMed ID: 32638487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
    Wallentin L; Eriksson N; Olszowka M; Grammer TB; Hagström E; Held C; Kleber ME; Koenig W; März W; Stewart RAH; White HD; Åberg M; Siegbahn A
    PLoS Med; 2021 Jan; 18(1):e1003513. PubMed ID: 33439866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.
    Sabatine MS; Morrow DA; de Lemos JA; Gibson CM; Murphy SA; Rifai N; McCabe C; Antman EM; Cannon CP; Braunwald E
    Circulation; 2002 Apr; 105(15):1760-3. PubMed ID: 11956114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of brain natriuretic peptide after acute myocardial infarction.
    Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries.
    Hjort M; Eggers KM; Lindhagen L; Agewall S; Brolin EB; Collste O; Daniel M; Ekenbäck C; Frick M; Henareh L; Hofman-Bang C; Malmqvist K; Spaak J; Sörensson P; Y-Hassan S; Tornvall P; Lindahl B
    Clin Chem; 2019 Aug; 65(8):1023-1030. PubMed ID: 31072836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between Troponin-I and B-Type Natriuretic Peptide Level in Acute Myocardial Infarction Patients with Heart Failure.
    Islam MN; Alam MF; Debnath RC; Aditya GP; Ali MH; Hossain MA; Siddique SR
    Mymensingh Med J; 2016 Apr; 25(2):226-31. PubMed ID: 27277352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15.
    Bettencourt P; Ferreira-Coimbra J; Rodrigues P; Marques P; Moreira H; Pinto MJ; Guimarães JT; Lourenço P
    ESC Heart Fail; 2018 Dec; 5(6):1017-1022. PubMed ID: 30144302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction.
    Palmer BR; Pilbrow AP; Yandle TG; Frampton CM; Richards AM; Nicholls MG; Cameron VA
    J Am Coll Cardiol; 2003 Mar; 41(5):729-36. PubMed ID: 12628714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    Olivier A; Girerd N; Michel JB; Ketelslegers JM; Fay R; Vincent J; Bramlage P; Pitt B; Zannad F; Rossignol P;
    Int J Cardiol; 2017 Aug; 241():344-350. PubMed ID: 28284500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma BNP Levels and Diuretics Use as Predictors of Cardiovascular Events in Patients with Myocardial Infarction and Impaired Glucose Tolerance.
    Shindo K; Fukuda H; Hitsumoto T; Ito S; Kim J; Washio T; Kitakaze M
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):79-88. PubMed ID: 32076931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
    Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
    JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.